Key facts
- It has raised $3.3M across 5 recorded rounds; the latest was Seed Round ($1.1M) in Dec 2024.
- Notable investors include MedTech Innovator, Virginia Innovation Partnership Corporation, Virginia Venture Partners, CAV Angels, Alamo Angels — 8 tracked in total.
- Liquet Medical has filed 5 Form Ds with the SEC since 2021, most recently May 2025 ($615K sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Liquet Medical
Funding rounds
5 roundsAbout Liquet Medical
Developer of a medical device designed to transform the way vascular disease is treated through localized drug delivery. The company's patent-protected device offers several benefits, like a dual-tip infusion catheter, real-time pressure monitoring, and a flow-directed placement balloon, enabling healthcare professionals to focus on patient outcomes and healthcare sustainability.
- Sector
- Healthcare
- HQ
- Glen Allen, VA, United States
- Founded
- 2020
- Employees
- 5
- Website
- liquetmedical.com/
- Ownership
- Privately Held (backing)
Liquet Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liquet Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liquet Medical in its N-PORT filings yet. We sweep new filings monthly.